ATI Physical Therapy

ATIP · OTC

Price unavailable right now.

No price history for this range.

Key indicators

ATIP profitability and balance sheet ratios

EPS -$1.39 in Dec 2024, against -$1.35 a year earlier.

EPS by quarter
PeriodEPS
Q1 FY23-$6.41
Q2 FY23-$5.54
Q3 FY23-$3.66
Q4 FY23-$1.35
Q1 FY24-$3.51
Q2 FY24-$0.8594
Q3 FY24-$7.76
Dec 2024-$1.39

Where the money went

Q3 FY24, from revenue to net income

ATI Physical Therapy brought in $190.0M of revenue in Q3 FY24, +7.1% on a year earlier. It made a net loss of $40.8M.

Revenue
$190.0M
Costs, expenses and taxes
$230.8M
Net income
−$40.8M
Net margin
-21.5%

Income statement

Revenue and profit by reporting period

Revenue
Net income
ATIP income statement, quarterly
Line itemQ1 FY24Q2 FY24Q3 FY24
Revenue$181.5M$188.1M$190.0M
Gross profit$181.5M$134.9M$190.0M
Operating income−$4.8M$6.6M$1.1M
Net income−$19.3M−$10.6M−$40.8M
Diluted EPS-$4.61-$2.43-$9.38

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
ATIP balance sheet, quarterly
Line itemJun 2024Sep 2024Dec 2024
Total assets$1.0B$1.0B$1.0B
Total liabilities$0.9B$0.9B$0.9B
Shareholder equity$0.1B$0.1B$0.1B
Cash and short-term investments$0.0B$0.0B$0.0B
Total debt$0.5B$0.6B$0.5B

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
ATIP cash flow, quarterly
Line itemQ1 FY24Q2 FY24Q3 FY24
Operating cash flow−$39.1M$11.2M−$3.5M
Investing cash flow−$2.5M−$2.7M−$3.6M
Financing cash flow$28.5M$0.7M−$2.4M
Capital expenditure−$2.7M−$3.0M−$3.6M
Free cash flow−$41.7M$8.2M−$7.2M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.